Dr. Carl Christian Gilhuus-Moe, PhD

Dr. Gilhuus-Moe is Chairman of the Board of Norway Health Tech and Senior Advisor of NeoMed Management.

Dr. Gilhuus-Moe is Chairman of the Board of Norway Health Tech, Norways largest health cluster consisting of 225 companies, hospitals, finance, knowledge and research institutions focusing on health innovation that facilitate development of health care products and services. He is a Senior Advisor of NeoMed Management, a Europe-based venture capital fund focused on international healthcare and medical technology.

Dr. Gilhuus-Moe is chairman of the board of Sonitor Technologies AS and board member of Respinor AS. He is also an active investor in several other health startups and companies in Norway. He was chairman of the board for both SINTEF-Unimed (the Norwegian Institute of Technology) and the European Committee for Clinical Laboratory Standardization (ECCLS). He was the founding President and CEO of Dynal Biotech AS, now part of Thermo Fisher Inc. Prior to that he was a member of the executive group, Vice President and head of Hafslund-Nycomed ASA's diagnostic division (now part of Abbot Inc). Dr. Gilhuus-Moe is an Honorable Fellow of the National Academy of Clinical Biochemistry (US). These executive and strategic positions and service on the board of directors of these and other companies have allowed him to develop expertise in the deployment of strategic growth initiatives within the industry and bring valuable, external insight to our board and organization. Dr. Gilhuus-Moe is trained at the Swedish Institute of Management, the Sloan School of Management at the Massachusetts Institute of Technology and earned a Ph.D in clinical biochemistry from the University of Oslo.

Dr. Gilhuus-Moe, Excite International Executive Board

Dr. Gilhuus-Moe, Phd

Chairman of the Board of Norway Health Tech

Work with us. EXCITE International can assist you in facilitating multi-jurisdictional clinical trials through its partnership with government, clinical experts, methodology centres and health system decision makers.